(Q36675532)

15 August 2017

Clinical effects of gemifloxacin on the delay of tuberculosis treatment (English)

1 reference

15 August 2017

1 reference

Seo Yun Kim

1

1 reference

15 August 2017

Jae-Joon Yim

2

1 reference

15 August 2017

Jong Sun Park

3

1 reference

15 August 2017

Sung Soo Park

4

1 reference

15 August 2017

Eun Young Heo

5

1 reference

15 August 2017

Chang-Hoon Lee

6

1 reference

15 August 2017

Hee Soon Chung

7

1 reference

15 August 2017

Deog Kyeom Kim

8

1 reference

15 August 2017

4 March 2013

1 reference

Journal of Korean Medical Science

15 August 2017

1 reference

15 August 2017

28

1 reference

15 August 2017

3

1 reference

15 August 2017

378-382

1 reference

Fluoroquinolones for the treatment of pulmonary tuberculosis

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Patient and health care system delays in the diagnosis and treatment of tuberculosis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Activity of amoxicillin/clavulanate in patients with tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Antibiotic-Resistant Pneumococcal Disease in South African Children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594600

WHO global tuberculosis control report 2010. Summary

20 October 2018

1 reference

12 December 2020

Activity of quinolones against mycobacteria

1 reference

12 December 2020

The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis

1 reference

12 December 2020

Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia

1 reference

12 December 2020

10.3346/JKMS.2013.28.3.378

Identifiers

DOI

1 reference

release_zqyafdf7abhjpdbojt2eh5m2ge

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zqyafdf7abhjpdbojt2eh5m2ge

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

23486643

1 reference